3,243 articles
This week’s patent news features a free masterclass on patent filing, Nokia and Daimler’s settlement of a SEP dispute, and the EU’s alternative proposal to the WTO on…
This week’s Indian patent statistics reveal a notable decline in patent publications and grants compared to the previous week. The report offers a comprehensive breakdown by city and…
Join the third session of the Certificate Master Class on IP to learn about the patent process in India and strategic patent management. The webinar includes presentations from…
This session of the masterclass explored patentability criteria and search strategies for AI and software inventions. Attendees learned about the patent process, prior art search, and practical considerations…
This week, the Indian Trademark Office experienced a notable decline in both examinations and hearing notices. The report details week-on-week and jurisdictional statistics, offering an analytical overview of…
Session 2 of the Intellectual Property Masterclass by BananaIP and NASSCOM will focus on patents and their relevance for startups. Senior experts will discuss patentability, patent searches, and…
The post offers updated and amended versions of major Indian intellectual property statutes following the abolition of the IPAB. Downloadable resources and detailed amendment summaries are provided for…
This bulletin examines recent trademark infringement cases in India and abroad, including Mankind Pharma's injunction and Epic Games’ lawsuit. It also features brand licensing news and updates on…
The article examines India’s policy on compulsory licensing for COVID-related medical technologies, echoing Prof. Arul Scaria’s critique of current government inaction. It highlights the legal and historical basis…
Indian patent statistics for the week reveal increased early publications and patent grants, alongside a decrease in ordinary publications. The data provides a comprehensive overview of patent activity…
Natco Pharma has withdrawn its compulsory license application for Baricitinib following an agreement with Eli Lilly. The Indian Patent Office has extended procedural deadlines, and other significant updates…